| Literature DB >> 27453960 |
Maria I Danila1, Ryan C Outman1, Elizabeth J Rahn1, Amy S Mudano1, Tammi F Thomas1, David T Redden1, Jeroan J Allison2, Fred A Anderson2, Julia P Anderson3, Peter M Cram4, Jeffrey R Curtis1, Liana Fraenkel5, Susan L Greenspan6, Andrea Z LaCroix7, Sumit R Majumdar8, Michael J Miller9, Jeri W Nieves10, Monika M Safford11, Stuart L Silverman12, Ethel S Siris13, Daniel H Solomon13, Amy H Warriner1, Nelson B Watts14, Robert A Yood15, Kenneth G Saag1.
Abstract
OBJECTIVE: To develop an innovative and effective educational intervention to inform patients about the need for osteoporosis treatment and to determine factors associated with its online uptake.Entities:
Keywords: Osteoporosis; Patient directed intervention; Treatment barriers; Video-based intervention
Year: 2016 PMID: 27453960 PMCID: PMC4955389 DOI: 10.1016/j.conctc.2016.06.010
Source DB: PubMed Journal: Contemp Clin Trials Commun ISSN: 2451-8654
Fig. 1Intervention design for women in the Activating Patients at Risk for OsteoPOroSis (APROPOS) Study. (a) Nominal groups were used to generate a list of barriers (Appendix A) that experts reduced to those potentially modifiable by an intervention. Potentially modifiable barriers were ranked by participants on surveys and these responses were used to tailor the first layer of the intervention, followed by the second layer of tailoring (self-identified race/ethnicity) (b). Participants received video segments with three components: an introduction, videos tailored based on participant ranked specific barriers or general osteoporosis treatment barriers, and a video on “How to talk to your doctor” communication techniques *Women who self-identified other than Caucasian, African American, and/or Hispanic comprised less than 2% of our intervention population and received intervention videos with Caucasian female educators and patient actresses.
Demographic characteristics of respondents (N = 1342) randomized to the intervention, divided by website activity.a
| Logged onto website within 60 days | |||
|---|---|---|---|
| Yes | No | p-value | |
| n = 377 | n = 965 | ||
| Age, mean (SD), years | 72.9(7.0) | 75.7(8.2) | <0.0001 |
| Age1 | |||
| 60–69 | 132(35.0%) | 248(25.7%) | <0.0001 |
| 70–79 | 172(45.6%) | 393(40.7%) | |
| 80–89 | 68(18.0%) | 281(29.1%) | |
| 90+ | 5(1.3%) | 43(4.5%) | |
| Race/ethnicity | |||
| Caucasian | 363(96.3%) | 884(91.6%) | 0.0027 |
| Other | 14(3.7%) | 81(8.4%) | |
| Recruitment site | |||
| Birmingham, AL | 44(11.7%) | 162(16.8%) | 0.017 |
| Cincinnati, OH | 35(9.3%) | 110(11.4%) | |
| Los Angeles, CA | 46(12.2%) | 79(8.2%) | |
| New York, NY | 52(13.8%) | 115(11.9%) | |
| Pittsburgh, PA | 55(14.6%) | 141(14.6%) | |
| Seattle, WA | 82(21.8%) | 167(17.3%) | |
| Worcester, MA | 63(16.7%) | 191(19.8%) | |
| Education2 | |||
| Some high school or less | 3(0.8%) | 37(3.9%) | <0.0001 |
| High school graduate | 41(11.0%) | 214(22.5%) | |
| Some college or more | 329(88.2%) | 701(73.6%) | |
| Concerned about osteoporosis3 | 215(61.6%) | 495(57.3%) | 0.1511 |
| No past treatment for osteoporosis4 | 105(28.5%) | 344(38.0%) | 0.0013 |
| Comorbidities | |||
| Depression5 | 70(19.4%) | 202(21.9%) | 0.3411 |
| Readiness to behavior change | |||
| Pre-contemplative | 239(74.2%) | 583(75.3%) | 0.7018 |
| Contemplative | 83(25.8%) | 191(24.7%) | |
| Phone/email provided | |||
| Phone and email | 219(58.1%) | 253(26.2%) | <0.0001 |
| Email only | 77(20.4%) | 92(9.5%) | |
| Phone only | 53(14.1%) | 374(38.8%) | |
| Neither | 28(7.4%) | 246(25.5%) | |
| Health literacy | |||
| Adequate | 350(94.1%) | 794(84.8%) | <0.0001 |
| Inadequate | 22(5.9%) | 142(15.2%) | |
1missing for 2 persons, 2missing for 17, 3missing for 130, 4missing for 67, 5missing for 58, 6missing for 246.
For categorical variables data is presented as N(%).
readiness to behavior change assessed with a modified form of the Weinstein Precaution Adoption Process Model (PAPM).
Seven osteoporosis treatment barriers identified and ranked by survey respondents.
| Barrier | Ranked#1 | Ranked#2 | Ranked#3 | Cumulative |
|---|---|---|---|---|
| Osteonecrosis of the jaw concerns | 128 | 59 | 135 | 322 |
| Gastrointestinal problems | 109 | 46 | 136 | 291 |
| Atypical fracture concerns | 101 | 48 | 131 | 280 |
| Preference for natural supplements | 120 | 32 | 115 | 277 |
| Drug inefficacy concerns | 73 | 51 | 142 | 266 |
| Medication interaction concerns | 67 | 23 | 142 | 232 |
| Difficulty remembering medication | 29 | 11 | 139 | 179 |
Cumulative represents the total number of persons who ranked each of the barriers as#1,#2 or#3.
Endorsed by all participants who ranked 4 or more barriers equally.
Fig. 3Tailoring of video segments for women in the intervention arm of the Activating Patients at Risk for OsteoPOroSis (APROPOS) Study. Individuals were assigned video segments based on four mutually exclusive, hierarchical levels: Group I: Ranked barriers to osteoporosis treatment, Group II: Other barriers identified on the survey including a physician recommended break from medications and/or ≥5 years treatment, or concerns about long term adverse effects as identified on the Patients’ Views about Osteoporosis (osteo) and therapy scale, Group III: Readiness to behavior change based on the Weinstein Precaution Adoption Process Model (PAPM), or Group IV: Previous treatment history. ONJ, osteonecrosis of the jaw.
Fig. 4Proportion of participants interacting with the video program online by contact information. Phone only, email only, phone & email indicate phone number, email, or both provided on baseline survey, respectively. No email/phone indicates no email or phone number was provided on the baseline survey. Warm handoff call informed participant of reason for intervention materials, as well as attempted to identify and address barriers to watching videos. Reminder package contained copy of introductory letter detailing instructions on how to access video program online and another DVD with individualized video intervention. * Timing of these materials varied up to ∼1week. +Varied based on when/if warm handoff call completed. IVR, interactive voice-response [5].
Adjusted (aOR) and unadjusted odds ratio (OR) (and 95% confidence intervals) estimates of logging on the website within 60 days of intervention initiation.
| Characteristic | Category | Number (%) | Crude | Adjusted | Adjusted | |||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |||
| No | 81 (21.5%) | ref | ||||||
| Yes | 296 (78.5%) | 6.57 | (4.97, 8.68) | 5.10 | (3.56, 7.31) | 6.07 | (4.53, 8.14) | |
| Phone | No | 105 (27.8%) | ref | |||||
| Yes | 272 (72.2%) | 1.40 | (1.08, 1.81) | 1.23 | (0.86. 1.75) | |||
| Age, every 10y | 0.66 | (0.54, 0.74) | 0.74 | (0.60, 0.94) | 0.82 | (0.66, 0.95) | ||
| Race/ethnicity | Not Caucasian | 14 (3.7%) | ref | |||||
| Caucasian | 363 (96.3%) | 2.38 | (1.33, 4.24) | 1.67 | (0.72, 3.85) | 1.76 | (0.95, 3.27) | |
| Education | Less than high school | 3 (0.8%) | ref | |||||
| High school | 41 (11.0%) | 2.36 | (0.70, 8.03) | 1.17 | (0.22, 6.30) | |||
| Some college or more | 329 (88.2%) | 5.79 | (1.77, 18.91) | 1.80 | (0.35, 9.28) | |||
| Recruitment site | Worcester, MA | 63 (16.7%) | ref | |||||
| Birmingham, AL | 44 (11.7%) | 0.82 | (0.53, 1.28) | 0.71 | (0.39, 1.32) | |||
| Cincinnati, OH | 35 (9.3%) | 0.97 | (0.60, 1.55) | 0.79 | (0.43, 1.45) | |||
| Los Angeles, CA | 46 (12.2%) | 1.77 | (1.11, 2.80) | 1.47 | (0.81, 2.65) | |||
| New York, NY | 52 (13.8%) | 1.37 | (0.89, 2.12) | 1.37 | (0.78, 2.41) | |||
| Pittsburgh, PA | 55 (14.6%) | 1.18 | (0.78, 1.80) | 0.87 | (0.49, 1.54) | |||
| Seattle, WA | 82 (21.8%) | 1.49 | (1.01, 2.20) | 1.17 | (0.71, 1.95) | |||
| Concerned about osteoporosis | No | 133 (38.2%) | ref | |||||
| Yes | 215 (61.8%) | 1.21 | (0.93, 1.56) | 1.15 | (0.82, 1.61) | |||
| Depression | No | 70 (19.4%) | ref | |||||
| Yes | 290 (80.6%) | 0.86 | (0.64, 1.16) | 0.66 | (0.45, 0.98) | 0.72 | (0.51, 0.996) | |
| Prior osteoporosis drug use | No | 264 (71.5%) | ref | |||||
| Yes | 105 (28.5%) | 1.54 | (1.18, 2.00) | 0.79 | (0.55, 1.12) | |||
| Readiness to behavior change | Precontemplative | 239 (74.2%) | ref | |||||
| Contemplative | 83 (25.8%) | 1.06 | (0.79, 1.43) | 0.96 | (0.64, 1.44) | |||
| Health literacy | Inadequate | 22 (5.9%) | ref | |||||
| Adequate | 350 (94.1%) | 2.85 | (1.79, 4.54) | 1.58 | (0.79, 3.18) | |||
Readiness to behavior change assessed using a modified form of the Weinstein Precaution Adoption Process Model (PAPM).
Adjusted for all characteristics.
Adjusted for age, email, race/ethnicity, depression.
Barriers identified
| 1. Being raised in a family where we were wary and fearful of any kind of medications |
| 2. Being told by my dentist that I could get bone and jaw cancer after taking the medication for a few years. |
| 3. By making significant lifestyle changes to be more healthy (e.g., combining the right kind of food, activity, reducing stress, and other behaviors), it should not be necessary to take the medication. |
| 4. Experiencing GI problems when I take oral medications |
| 5. Hating the thought of taking any and all medications |
| 6. Having a mother and grandmother who took similar medicines without any benefit |
| 7. Having concerns about the side effects after reading studies and other information that I found. |
| 8. Having had previous negative reactions when taking other drugs. |
| 9. Having to pay a lot for this type of medication |
| 10. Having to remember to take medication. |
| 11. Hearing that these medications can also make your bones brittle |
| 12. Liking to try natural remedies first |
| 13. Not believing that my doctor is acting in my best interest |
| 14. Not having insurance coverage for this type of medication since it is considered preventative not life-threatening |
| 15. Not knowing how these medications would interact with other medications |
| 16. Not knowing if my doctor really knows what is right for me |
| 17. Not knowing what the long term effect might be of a drug that can actually change your bone |
| 18. Not thinking that there have been enough studies done to really know about the side effects of these medications especially when someone has other medical conditions (e.g. for diabetes) |
| 19. Taking medication could cause me to have more frequent doctor visits |
| 20. Taking these medicines is complex and inconvenient |
| 21. Trying to get more calcium from food to avoid taking medications (note: dietary supplement) |
| 22. Wondering whether there will be something better that will come along if I wait |
| 23. Worrying about the cumulative/long-term side effects of these drugs because of their toxicity. |
| 24. Worrying about the possible side effects of this medication |
| 25. Worrying how the medication will affect my digestive system--based on other meds that I have taken. |